Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?
Zhang J, Lin S, Jiang D, Li M, Chen Y, Li J, Fan J.
Liver Int. 2020 Mar;40(3):496-508. doi: 10.1111/liv.14369. Epub 2020 Jan 13.
Decoding cell death signals in liver inflammation.
Brenner C, Galluzzi L, Kepp O, Kroemer G.
J Hepatol. 2013 Sep;59(3):583-94. doi: 10.1016/j.jhep.2013.03.033. Epub 2013 Apr 6.
Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease.
Hammoutene A, Rautou PE.
J Hepatol. 2019 Jun;70(6):1278-1291. doi: 10.1016/j.jhep.2019.02.012. Epub 2019 Feb 21.
ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
Kwo PY, Cohen SM, Lim JK.
Am J Gastroenterol. 2017 Jan;112(1):18-35. doi: 10.1038/ajg.2016.517. Epub 2016 Dec 20.
Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease.
Tong X, Song Y, Yin S, Wang J, Huang R, Wu C, Shi J, Li J.
Chin Med J (Engl). 2022 Jul 20;135(14):1653-1663. doi: 10.1097/CM9.0000000000002310.
Si-Wu-Tang attenuates hepatocyte PANoptosis and M1 polarization of macrophages in non-alcoholic fatty liver disease by influencing the intercellular transfer of mtDNA.
Ma Z, Xie K, Xue X, Li J, Yang Y, Wu J, Li Y, Li X.
J Ethnopharmacol. 2024 Jun 28;328:118057. doi: 10.1016/j.jep.2024.118057. Epub 2024 Mar 20.
UCP1 governs liver extracellular succinate and inflammatory pathogenesis.
Mills EL, Harmon C, Jedrychowski MP, Xiao H, Garrity R, Tran NV, Bradshaw GA, Fu A, Szpyt J, Reddy A, Prendeville H, Danial NN, Gygi SP, Lynch L, Chouchani ET.
Nat Metab. 2021 May;3(5):604-617. doi: 10.1038/s42255-021-00389-5. Epub 2021 May 17.
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight.
Ballestri S, Nascimbeni F, Romagnoli D, Baldelli E, Targher G, Lonardo A.
Int J Mol Sci. 2016 Mar 9;17(3):355. doi: 10.3390/ijms17030355.
Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, de Martel C.
Lancet Gastroenterol Hepatol. 2022 Aug;7(8):724-735. doi: 10.1016/S2468-1253(22)00050-4. Epub 2022 May 14.
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future.
Chuah KH, Chan WK.
Clin Mol Hepatol. 2023 Apr;29(2):401-403. doi: 10.3350/cmh.2023.0062. Epub 2023 Feb 28.
